Search

Your search keyword '"Diez, O."' showing total 419 results

Search Constraints

Start Over You searched for: Author "Diez, O." Remove constraint Author: "Diez, O."
419 results on '"Diez, O."'

Search Results

1. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

2. 139P Breast cancer risk estimation (CanRisk tool) and perception in unaffected women with family history of breast cancer

3. 12P Prevalence of functional and genomic homologous recombination deficiency (HRD) in germline RAD51C/D patients

4. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

5. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

6. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

7. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

11. First international workshop of the ATM and Cancer Risk Group (4–5 December 2019)

12. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

14. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

15. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

16. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

17. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

18. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

19. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

20. First international workshop of the ATM and cancer risk group (4-5 December 2019).

21. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

22. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.

23. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

24. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects

25. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

26. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

27. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

28. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

32. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

33. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

34. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

35. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

36. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

37. A multi-centre international quality control study comparing mRNA splicing assay protocols and reporting practices from the ENIGMA consortium

38. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

39. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

40. The spectrum of fancm protein truncating variants in European breast cancer cases.

41. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

42. Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families.

43. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

44. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

45. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

46. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

47. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

48. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

49. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

50. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Catalog

Books, media, physical & digital resources